Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Dodd

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Applied Ergonomics|September 1, 1970
Personnel selection - 3. InterviewingJ H Dodd
Applied Ergonomics|December 1, 1970
Personnel selection--4. ConclusionJ H Dodd
Applied Ergonomics|June 1, 1970
Personnel selection--2. TestingJ H Dodd
International Archives of Allergy and Immunology|January 1, 1993
Experimental antiasthmatic activity of RWJ 22108: a bronchoselective calcium entry blockerD M Ritchie, T Kirchner, J B Moore, et al.
Molecular Pharmacology|December 1, 1990
Structure-activity relationships for enhancement of adenosine A1 receptor binding by 2-amino-3-benzoylthiophenesR F Bruns, J H Fergus, L L Coughenour, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Potent inhibitors of the MAP kinase p38J R Henry, K C Rupert, J H Dodd, et al.
Drug Design and Discovery|May 1, 1997
Design and discovery of RWJ 22108--a novel bronchoselective calcium channel blockerJ H Dodd, C F Schwender, J B Moore, et al.
Drug Design and Discovery|January 1, 1993
Synthesis and biological properties of RWJ 22108, a bronchoselective calcium channel blockerJ H Dodd, C F Schwender, R A Conley, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
The development of novel and selective p56lck tyrosine kinase inhibitorsJ L Bullington, J C Cameron, J E Davis, et al.
Journal of Medicinal Chemistry|October 23, 1998
6-Amino-2-(4-fluorophenyl)-4-methoxy-3- (4-pyridyl)-1H-pyrrolo[2, 3-b]pyridine (RWJ 68354): a potent and selective p38 kinase inhibitorJ R Henry, K C Rupert, J H Dodd, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Applied Ergonomics|September 1, 1970
Personnel selection - 3. InterviewingJ H Dodd
Applied Ergonomics|December 1, 1970
Personnel selection--4. ConclusionJ H Dodd
Applied Ergonomics|June 1, 1970
Personnel selection--2. TestingJ H Dodd
International Archives of Allergy and Immunology|January 1, 1993
Experimental antiasthmatic activity of RWJ 22108: a bronchoselective calcium entry blockerD M Ritchie, T Kirchner, J B Moore, et al.
Molecular Pharmacology|December 1, 1990
Structure-activity relationships for enhancement of adenosine A1 receptor binding by 2-amino-3-benzoylthiophenesR F Bruns, J H Fergus, L L Coughenour, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Potent inhibitors of the MAP kinase p38J R Henry, K C Rupert, J H Dodd, et al.
Drug Design and Discovery|May 1, 1997
Design and discovery of RWJ 22108--a novel bronchoselective calcium channel blockerJ H Dodd, C F Schwender, J B Moore, et al.
Drug Design and Discovery|January 1, 1993
Synthesis and biological properties of RWJ 22108, a bronchoselective calcium channel blockerJ H Dodd, C F Schwender, R A Conley, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
The development of novel and selective p56lck tyrosine kinase inhibitorsJ L Bullington, J C Cameron, J E Davis, et al.
Journal of Medicinal Chemistry|October 23, 1998
6-Amino-2-(4-fluorophenyl)-4-methoxy-3- (4-pyridyl)-1H-pyrrolo[2, 3-b]pyridine (RWJ 68354): a potent and selective p38 kinase inhibitorJ R Henry, K C Rupert, J H Dodd, et al.
Pageof 1